Centessa Pharmaceuticals Statistics

Total Valuation

CNTA has a market cap or net worth of $889.27 million. The enterprise value is $744.63 million.

Market Cap	889.27M
Enterprise Value	744.63M

Important Dates

The last earnings date was Monday, May 13, 2024, after market close.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

CNTA has 100.48 million shares outstanding.

Shares Outstanding	100.48M
Owned by Insiders (%)	2.07%
Owned by Institutions (%)	75.77%
Float	49.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	129.76
Forward PS	n/a
PB Ratio	4.13
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	108.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.37, with a Debt / Equity ratio of 0.40.

Current Ratio	10.37
Quick Ratio	n/a
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.22

Financial Efficiency

Return on equity (ROE) is -56.10% and return on invested capital (ROIC) is -54.58%.

Return on Equity (ROE)	-56.10%
Return on Assets (ROA)	-38.00%
Return on Capital (ROIC)	-54.58%
Revenue Per Employee	$90,171
Profits Per Employee	-$1.82M
Employee Count	76
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	-25.25M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +89.94% in the last 52 weeks. The beta is 1.45, so CNTA's price volatility has been higher than the market average.

Beta (1Y)	1.45
52-Week Price Change	+89.94%
50-Day Moving Average	10.32
200-Day Moving Average	8.12
Relative Strength Index (RSI)	39.59
Average Volume (30 Days)	223,725

Short Selling Information

Short Interest	1.79M
Short Previous Month	1.28M
Short % of Shares Out	2.06%
Short % of Float	n/a
Short Ratio (days to cover)	7.04

Income Statement

In the last 12 months, CNTA had revenue of $6.85 million and -$138.42 million in losses. Loss per share was -$1.41.

Revenue	6.85M
Gross Profit	6.85M
Operating Income	-164.12M
Pretax Income	-163.67M
Net Income	-138.42M
EBITDA	-152.62M
EBIT	-153.58M
Loss Per Share	-$1.41

Full Income Statement

Balance Sheet

The company has $230.18 million in cash and $85.54 million in debt, giving a net cash position of $144.63 million or $1.44 per share.

Cash & Cash Equivalents	230.18M
Total Debt	85.54M
Net Cash	144.63M
Net Cash Per Share	$1.44
Equity / Book Value	215.16M
Book Value Per Share	2.14
Working Capital	257.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$149.79 million and capital expenditures -$81,000, giving a free cash flow of -$149.87 million.

Operating Cash Flow	-149.79M
Capital Expenditures	-81,000
Free Cash Flow	-149.87M
FCF Per Share	-$1.50

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -2,394.79% and -2,019.80%.

Gross Margin	100.00%
Operating Margin	-2,394.79%
Pretax Margin	-2,388.28%
Profit Margin	-2,019.80%
EBITDA Margin	-2,227.02%
EBIT Margin	-2,241.05%
FCF Margin	-2,186.94%

Dividends & Yields

CNTA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.21%
Shareholder Yield	-5.21%
Earnings Yield	-15.57%
FCF Yield	-16.85%

Analyst Forecast

The average price target for CNTA is $10.00, which is 12.74% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	12.74%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	96.21%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CNTA has an Altman Z-Score of 0.76. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.76
Piotroski F-Score	n/a